Sign In
to Vote &
Create Storyboards.
 
Djokovic has 80% stake in biotech firm developing Covid drug QuantBioRes is working on a treatment not a vaccine, but CEO says tennis star is 'not anti-vax' Novak Djokovic is the controlling shareholder in a Danish biotech firm aiming to develop a treatment for Covid-19 that does not involve vaccination, it has emerged. The world No 1, who was deported from Australia this week after the government cancelled his visa in a dispute over a medical exemption relating to his unvaccinated status, bought an 80% stake in QuantBioRes in 2020.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard